title: Association between H-RAS T81C genetic polymorphism and gastrointestinal cancer risk: a population based case-control study in China.
abstract: BACKGROUND
  Gastrointestinal cancer, such as gastric, colon and rectal cancer, is a major medical and economic burden worldwide. However, the exact mechanism of gastrointestinal cancer development still remains unclear. RAS genes have been elucidated as major participants in the development and progression of a series of human tumours and the single nucleotide polymorphism at H-RAS cDNA position 81 was demonstrated to contribute to the risks of bladder, oral and thyroid carcinoma. Therefore, we hypothesized that this polymorphisms in H-RAS could influence susceptibility to gastrointestinal cancer as well, and we conducted this study to test the hypothesis in Chinese population.
  
  
  METHODS
  A population based case-control study, including 296 cases with gastrointestinal cancer and 448 healthy controls selected from a Chinese population was conducted. H-RAS T81C polymorphism was genotyped by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) assay.
  
  
  RESULTS
  In the healthy controls, the TT, TC and CC genotypes frequencies of H-RAS T81C polymorphism, were 79.24%, 19.87% and 0.89%, respectively, and the C allele frequency was 10.83%. Compared with TT genotype, the TC genotype was significantly associated with an increased risk of gastric cancer (adjusted OR = 3.67, 95%CI = 2.21-6.08), while the CC genotype showed an increased risk as well (adjusted OR = 3.29, 95%CI = 0.54-19.86), but it was not statistically significant. In contrast, the frequency of TC genotype was not significantly increased in colon cancer and rectal cancer patients. Further analysis was performed by combining TC and CC genotypes compared against TT genotype. As a result, a statistically significant risk with adjusted OR of 3.65 (95%CI, 2.22-6.00) was found in gastric cancer, while no significant association of H-RAS T81C polymorphism with colon cancer and rectal cancer was observed.
  
  
  CONCLUSIONS
  These findings indicate, for the first time, that there is an H-RAS T81C polymorphism existing in Chinese population, and this SNP might be a low penetrance gene predisposition factor for gastric cancer.
authors.affiliation: Department of Epidemiology & Health Statistics, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, PR China.
authors.forename: Yongjing
authors.initials: Y
authors.lastname: Zhang
authors.forename: Mingjuan
authors.initials: M
authors.lastname: Jin
authors.forename: Bing
authors.initials: B
authors.lastname: Liu
authors.forename: Xinyuan
authors.initials: X
authors.lastname: Ma
authors.forename: Kaiyan
authors.initials: K
authors.lastname: Yao
authors.forename: Qilong
authors.initials: Q
authors.lastname: Li
authors.forename: Kun
authors.initials: K
authors.lastname: Chen
mesh_terms: D000368:Aged; D000483:Alleles; D016022:Case-Control Studies; D002681:China; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000208:ethnology* / Q000235:genetics* / Q000378:metabolism; D005787:Gene Frequency; D011905:Genes, ras; D006801:Humans; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D012306:Risk
references.citation: Cell Mol Life Sci. 2000 Oct;57(11):1613-36
references.pmid: 11092455
references.citation: Nature. 1982 Dec 23;300(5894):762-5
references.pmid: 7177195
references.citation: Lung Cancer. 2005 Sep;49(3):419-20
references.pmid: 15955593
references.citation: Oncogene Res. 1991;6(1):33-8
references.pmid: 1671796
references.citation: Oncogene. 2006 Aug 3;25(33):4620-7
references.pmid: 16532025
references.citation: Int J Cancer. 2002 Jul 20;100(3):249-60
references.pmid: 12115538
references.citation: Front Biosci. 1998 Aug 06;3:d887-912
references.pmid: 9696882
references.citation: Gastroenterology. 1987 Dec;93(6):1339-45
references.pmid: 3315826
references.citation: Int J Cancer. 2002 Feb 10;97(5):562-6
references.pmid: 11807778
references.citation: N Engl J Med. 2001 Sep 13;345(11):784-9
references.pmid: 11556297
references.citation: J Clin Epidemiol. 2003 Jan;56(1):1-9
references.pmid: 12589864
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):68-70
references.pmid: 12540507
references.citation: Hepatogastroenterology. 1999 May-Jun;46(27):2063-8
references.pmid: 10430398
references.citation: Int J Oncol. 2002 Aug;21(2):237-41
references.pmid: 12118316
references.citation: BMC Cancer. 2007 Jun 30;7:115
references.pmid: 17603900
references.citation: Cancer Res. 1990 Aug 15;50(16):4911-4
references.pmid: 2199031
references.citation: J Gastroenterol Hepatol. 2006 Jun;21(6):1036-41
references.pmid: 16724991
references.citation: Oncol Rep. 2001 Nov-Dec;8(6):1409-13
references.pmid: 11605075
references.citation: J Cell Physiol. 2007 Mar;210(3):740-9
references.pmid: 17133351
references.citation: J Cell Physiol. 2002 Aug;192(2):125-30
references.pmid: 12115718
references.citation: J Gastroenterol. 2006 Mar;41(3):185-92
references.pmid: 16699851
references.citation: Nucleic Acids Res. 1992 May 25;20(10):2427-34
references.pmid: 1598201
references.citation: J Tongji Med Univ. 1998;18(3):141-4
references.pmid: 10806811
references.citation: J Clin Lab Anal. 2005;19(6):229-32
references.pmid: 16302208
references.citation: Oral Oncol. 2006 Jul;42(6):607-13
references.pmid: 16488657
references.citation: Gastroenterology. 2000 Jun;118(6):1045-50
references.pmid: 10833479
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Arch Pathol Lab Med. 2002 Sep;126(9):1096-100
references.pmid: 12204060
references.citation: Cancer Res. 1987 Mar 1;47(5):1413-20
references.pmid: 2434216
references.citation: Cancer Genet Cytogenet. 2001 Apr 15;126(2):147-54
references.pmid: 11376808
references.citation: Hum Mol Genet. 2003 Apr 15;12(8):891-900
references.pmid: 12668612